NCT06337695: Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 36 planned
- Started
- 13 Aug 2026
- Primary completion
- 1 Dec 2030
- Arms
- Vedolizumab
- Results
- None posted
- 29 Mar 2024: Trial registered
- 13 Aug 2026: Trial started